Severely increased blood pressure in the emergency department

Annals of Emergency Medicine

Volumn 41, Issue 4, 2003, Pages 513-529

  Shayne, Philip H ^a   Pitts, Stephen R ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANOREXIGENIC AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CAPTOPRIL; CLONIDINE; CYANIDE; DECONGESTIVE AGENT; DIAZOXIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRILAT; ESMOLOL; FENOLDOPAM; GLYCERYL TRINITRATE; HYDRALAZINE; IBUPROFEN; LABETALOL; MONOAMINE OXIDASE INHIBITOR; NICARDIPINE; NIFEDIPINE; NITROPRUSSIDE SODIUM; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; PHENTOLAMINE; STEROID; THIOCYANATE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VASODILATOR AGENT;

ADULT; ANGINA PECTORIS; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; CASE REPORT; CLINICAL EXAMINATION; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DIASTOLIC BLOOD PRESSURE; DISEASE CLASSIFICATION; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG INDICATION; ECLAMPSIA; EMERGENCY TREATMENT; EMERGENCY WARD; FLUSHING; HEADACHE; HEART BLOCK; HEART FAILURE; HUMAN; HYPERTENSION; HYPOTENSION; INTOXICATION; KIDNEY ARTERY STENOSIS; MALE; METHEMOGLOBINEMIA; MUSCLE TWITCH; NAUSEA; ORTHOSTATIC HYPOTENSION; PHLEBITIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; SEDATION; STROKE; SWEATING; SYSTOLIC BLOOD PRESSURE; TACHYCARDIA; THORAX PAIN; THROAT DISEASE; VERTIGO; VOMITING;

EID: 0037381934     PISSN: 01960644     EISSN: None     Source Type: Journal    
DOI: 10.1067/mem.2003.114     Document Type: Article

References (73)

1. Chiang WK, Jamshahi B. Asymptomatic hypertension in the ED Am J Emerg Med. 1998;16:701-704.
2. Karras DJ, Wald DA, Harrigan RA, et al. Elevated blood pressure in an urban emergency department: prevalence and patient characteristics [abstract]. Acad Emerg Med. 2001;8:559.
3. Zampaglione B, Pascale C, Marchisio M, et al. Hypertensive urgencies and emergencies. Prevalence and clinical presentation. Hypertension. 1996;27:144-147.
4. Preston RA, Baltodano NM, Cienki J, et al. Clinical presentation and management of patients with uncontrolled, severe hypertension: results from a public teaching hospital. J Hum Hypertens. 1999;13:249-255
5. Joint National Committee on Prevention, Detection, and Treatment of High Blood Pressure. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1997;157:2413-2446.
6. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. JAMA. 1967;202:1028-1034.
7. Herlitz J, Karlson BW, Lindqvist J, et al. Prognosis during five years of follow-up among patients admitted to the emergency department with acute chest pain in relation to a history of hypertension. Blood Press. 1998;7:81-88.
8. Shea S, Misra D, Ehrlich MH, et al. Predisposing factors for severe, uncontrolled hypertension in an inner-city minority population. N Engl J Med. 1992;327:776-781.
9. Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med. 2001;345:479-486.
10. Cameron JS, Hicks J. Frederick Akbar Mahomed and his role in the description of hypertension at Guy's Hospital. Kidney Int. 1996;49:1488-1506.
11. Mancia G. Scipione Riva-Rocci. Clin Cardiol. 1997;20:503-504.
12. Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. HOT Study Group. Lancet. 1998;351:1755-1762.
13. Pignone M, Mulrow CE. Using cardiovascular risk profiles to individualize hypertensive treatment. BMJ. 2001;322:1164-1165.
14. Furberg CO, Psaty BM, Meyer JV. Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. Circulation. 1995;92:1326-1331.
15. Pahor M, Psaty BM, Alderman MH, et al. Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomized controlled trials. Lancet. 2000;356:1949-1954.
16. Agodoa LY, Appel L, Bakris GL, et al. Effect of ramipril vs. amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. JAMA. 2001;285:2719-2728.
17. ALLHAT Collaborative Research Group. Major cardiovascular events in hypertensive patients randomized to doxazosin vs. chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA. 2000;283:1967-1975.
18. Psaty BM, Smith NL, Siscovick DS, et al. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. JAMA. 1997;277:739-745.
19. Perez MI, Wright JM. Comparison of pharmacological interventions for hypertensive emergencies and urgencies. In: The Cochrane Library. Issue 2. Oxford, United Kingdom: Update Software; 2003.
20. Kaplan NM. Clinical Hypertension. 7th ed. Baltimore, MA: Williams & Wilkins; 1998.
21. Strandgaard S, Olesen J, Skinhoi E, et al. Autoregulation of brain circulation in severe arterial hypertension. BMJ. 1973;1:1507-1510.
22. Impey L. Severe hypotension and fetal distress following sublingual administration of nifedipine to a patient with severe hypertension at 33 weeks. Br J Obstet Gynecol. 1993;100:959-961.
23. O'Mailia JJ, Sander GE, Giles TD. Nifedipine-associated myocardial ischemia or infarction in the treatment of hypertensive urgencies. Ann Intern Med. 1987;107:185-186.
24. Schwartz M, Naschitz JE, Yeshurun D, et al. Oral nifedipine in the treatment of hypertensive urgency: cerebrovascular accident following a single dose. Arch Intern Med. 1990;150:686-687.
25. Wachter RM. Symptomatic hypotension induced by nifedipine in the acute treatment of severe hypertension. Arch Intern Med. 1987;147:556-558.
26. Calhoun DA, Oparil S. Treatment of hypertensive crisis. N Engl J Med. 1990;323:1177-1183.
27. Ferguson RK, Vlasses PH. How urgent is 'urgent' hypertension? Arch Intern Med. 1989;149:257-258.
28. Gifford RW. Management of hypertensive crises. JAMA. 1991;266:829-835.
29. Kaplan NM. Management of hypertensive emergencies. Lancet. 1994;344:1335-1338.
30. Ram CV. Immediate management of severe hypertension. Cardiol Clin. 1995;13:579-591.
31. Vaughan CJ, Delanty N. Hypertensive emergencies. Lancet. 2000;356:411-417.
32. Murphy C. Hypertensive emergencies. Emerg Med Clin North Am. 1995;13:973-1007.
33. Blumenfeld JD, Laragh JH. Management of hypertensive crises: the scientific basis for treatment decisions. Am J Hypertens. 2001;14:1154-1167.
34. Thach AM, Schultz PJ. Nonemergent hypertension. New perspectives for the emergency medicine physician. Emerg Med Clin North Am. 1995;13:1009-1035.
35. Pitts SR, Adams RP. Emergency department hypertension and regression to the mean. Ann Emerg Med. 1998;31:214-218.
36. Pitts SR, Heilpern K, Peters HL. Emergency department patients with very severe hypertension. Poster presented at: Annual Meeting of the Southeast Chapter of the Society for Academic Emergency Medicine, 1998; Atlanta, GA.
37. Peters H, Baldwin M, Clarke M. The utility of laboratory data in the evaluation of the aysmptomatic hypertensive patient [abstract]. Ann Emerg Med. 2002;40:S48.
38. Bartha GW, Nugent CA Routine chest roentgenograms and electrocardiograms. Usefulness in the hypertensive workup. Arch Intern Med. 1978;138:1211-1213.
39. Dimmitt SB, West JN, Littler WA. Limited value of chest radiography in uncomplicated hypertension [letter]. Lancet. 1989;2:104.
40. Grossman E, Ironi AN, Messerli FH. Comparative tolerability profile of hypertensive crisis treatments. Drug Safety. 1998;19:99-122.
41. Varon J, Marik PE. The diagnosis and management of hypertensive crises. Chest. 2000;118:214-227.
42. Post JB, Frishman WH. Fenoldopam: a new dopamine agonist for the treatment of hypertensive urgencies and emergencies. J Clin Pharmacol. 1998;38:2-13.
43. Abdelwahab W, Frishman W, Landau A. Management of hypertensive urgencies and emergencies. J Clin Pharmacol. 1995;35:747-762.
44. Tumlin JA, Dunbar LM, Oparil S, et al. Fenoldopam, a dopamine agonist, for hypertensive emergency: a multicenter randomized trial. Fenoldopam Study Group. Acad Emerg Med. 2000;7:653-662.
45. Grossman E, Messerli FH, Grodzicki T, et al. Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and pseudoemergencies? JAMA. 1996;276:1328-1331.
46. Messerli FH, Grossman E. The use of sublingual nifedipine: a continuing concern. Arch Intern Med. 1999;159:2259-2260.
47. Lip GY, Beevers M, Beevers DG. Complications and survival of 315 patients with malignant-phase hypertension. J Hypertens. 1995;13:915-924.
48. Tietjen CS, Hurn PO, Ulatowski JA, et al. Treatment modalities for hypertensive patients with intracranial pathology: options and risks. Crit Care Med. 1996;24:311-322.
49. Schwartz RB, Jones KM, Kalina P, et al. Hypertensive encephalopathy: findings on CT, MR imaging, and SPECT imaging in 14 cases. Am J Roentgenol. 1992;159:379-383.
50. Brott T, Lu M, Kothari R, et al. Hypertension and its treatment in the NINDS rt-PA stroke trial. Stroke. 1998;29:1504-1509.
51. Adams HP, Brott TG, Crowell RM, et al. Guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 1994;25:1901-1914.
52. Broderick JP, Adams HP Jr, Barsan W, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 1999;30:905-915.
53. Gandhi SK, Powers JC, Nomeir AM, et al. The pathogenesis of acute pulmonary edema associated with hypertension. N Engl J Med. 2001;344:17-22.
54. Hamilton RJ, Carter WA, Gallagher EJ. Rapid improvement of acute pulmonary edema with sublingual captopril. Acad Emerg Med. 1996;3:205-212.
55. Francis GS, Siegel RM, Goldsmith SR, et al. Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis. Ann Intern Med. 1985;103:1-6.
56. Hoffman JR, Reynolds S. Comparison of nitroglycerin, morphine and furosemide in treatment of presumed pre-hospital pulmonary edema. Chest. 1987;92:586-593.
57. Packer M, Coats AJ, Fowler MB, et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med. 2001;344:1651-1658.
58. Publication Committee for the VMAC Investigators. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure. A randomized controlled trial. JAMA. 2002;287:1531-1540.
59. First International Study of Infarct Survival Collaborative Group. Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. Lancet. 1986;2:57-66.
60. Pretre R, Von Segesser LK. Aortic dissection. Lancet. 1997;349:1461-1464.
61. Pastan S, Bailey J. Dialysis therapy. N Engl J Med. 1998;338:1428-1437.
62. Dubose TD. Vascular Disorders of the Kidney. 21st ed. Philadelphia, PA: WB Saunders; 2000.
63. Karras DJ, Heilpern KL, Riley LJ, et al. Urine dipstick as a screening test for serum creatinine elevation in emergency department patients with severe hypertension, Acad Emerg Med. 2002;9:27-34.
64. Davin JC, Ten Berge IJ, Weening JJ. What is the difference between IgA nephropathy and Henoch-Schönlein purpura nephritis? Kidney Int. 2001;59:823-834.
65. Safian RD, Textor SC. Renal-artery stenosis. N Engl J Med. 2001;344:431-442.
66. Lucas MJ, Leveno KJ, Cunningham FG. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med. 1995;333:201-205.
67. Mabie WC, Gonzalez AR, Sibai BM, et al. A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy. Obstet Gynecol. 1987;70:328-333.
68. Wide-Swensson DH, Ingemarsson I, Lunell NO, et al. Calcium channel blockade (isradipine) in treatment of hypertension in pregnancy: a randomized placebo-controlled study. Am J Obstet Gynecol. 1995;173:872-878.
69. Boehrer JD, Moliterno DJ, Willard JE, et al. Influence of labetalol on cocaine-induced coronary vasoconstriction in humans. Am J Med. 1993;94:608-610.
70. Gay GR, Loper KA. The use of labetalol in the management of cocaine crisis. Ann Emerg Med. 1988;17:282-283.
71. Ramoska E, Sacchetti AD. Propranolol-induced hypertension in treatment of cocaine intoxication. Ann Emerg Med. 1985;14:1112-1113.
72. Zeller KR, Von Kuhnert L, Matthews C. Rapid reduction of severe asymptomatic hypertension. A prospective, controlled trial. Arch Intern Med. 1989;149:2186-2189.
73. Chernow SM, Iserson KV, Criss E. Use of the emergency department for hypertension screening: a prospective study. Ann Emerg Med. 1987;16:180-182